Qiagen N.V. QIA.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Qiagen N.V. statistics & valuation
Market cap$7.0B
P / E16.5×
P / S3.3×
P / B1.9×
P / FCF15.6×
Dividend yield0.78%
Net margin20.3%
Return on equity11.2%
FCF margin21.4%
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Qiagen N.V. trades at about 16.6× earnings — below its 10-year norm (10-year range 17.9×–112.7×, median 26.5×).
16.6×
112.7×
Shaded band = 10-year range (17.9×–112.7×); dot = today's 16.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 62.2% | 48.9% | 62.8% | 64.7% |
| Operating margin | 24.9% | 10.1% | 22.7% | 26.9% |
| Net margin | 20.3% | 4.2% | 17.4% | 19.8% |
| FCF margin | 21.4% | 25.4% | 15.1% | 26.4% |
| Return on assets | 6.8% | 1.5% | 5.6% | 6.7% |
| Return on equity | 11.2% | 2.3% | 9.0% | 12.2% |
| Debt / equity | 0.44× | 0.24× | 0.24× | 0.42× |
| Current ratio | 3.90 | 1.88 | 1.99 | 2.46 |
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.